Introduction
In heart cells, Ca 2+ influx via Ca V 1.2 channels mediates excitation-contraction (E-C) coupling, controls action potential duration, and regulates gene expression. Ca V 1.2 channels are multi-subunit proteins composed minimally of a pore-forming α 1C and regulatory β and α 2 δ subunits (1) (2) (3) (4) . In adult ventricular cardiomyocytes, most Ca V 1.2 channels localize to transverse tubules where they lie in close proximity (~12 nm) and apposed to ryanodine receptors (RyR2) at dyadic junctions (5) . Dysregulation of Ca V 1.2 activity, surface density, or subcellular localization in cardiomyocytes can result in cardiac arrhythmias, heart failure, and sudden death.
Reconstitution experiments concluded that binding to β subunits is indispensable for α 1C trafficking to the cell surface (6) (7) (8) (9) (10) (11) (12) (13) (14) . The physiological relevance of this finding was initially supported by β 2 knockout mice, which were embryonic lethal, likely secondary to a decreased L-type Ca 2+ current (15) . An initial idea that β binding to the α-interaction domain (AID) of the α 1 -subunit I-II loop shielded an ER retention signal in the I-II loop to allow forward trafficking of the channel proved inadequate in subsequent experiments (9, (16) (17) (18) . Surprisingly, cardiomyocyte-specific, conditional deletion of the Cacnb2 gene in adult mice reduced β 2 protein by 96% but caused only a modest 29% reduction in Ca 2+ current, with no obvious cardiac impairment (19) . Interpretation of this result is ambiguous, however, as it is complicated by the remnant (~4%) β 2 expression as well as the presence other Ca V β isoforms expressed in adult cardiomyocytes (13) . Moreover, a contrasting viewpoint was provided by a study in which shRNA-mediated knockdown of β 2 in adult rat myocytes substantially diminished Ca 2+ current (20) . To definitively address the controversies regarding the role of β subunits in mediating trafficking and regulation of Ca 2+ channels in the heart, we created transgenic mice lines with 3 mutations in the AID, which renders the pore-forming α 1C subunit incapable of binding β subunits. With this new model, we definitively demonstrate in vivo that β subunit binding to α 1C is not required for trafficking and that the basal function of β-less Ca 2+ channels is only minimally altered. Instead, we found that the β subunit is obligatory for transducing β-adrenergic signals to cardiac Ca V 1.2 channels. Cardiac Ca V 1.2 channels are prominently upregulated by β-adrenergic agonists via activation of protein kinase A (PKA) (21, 22) as part of the fundamental flight-or-fight response, yet the detailed mechanisms by which PKA activates Ca V 1.2 remain unknown despite several decades of investigation. Recently, we reported that alanine substitution of all consensus, conserved PKA phosphorylation sites (> 22 serines/ threonines) in the α 1C subunit did not affect adrenergic regulation of CaV1.2 in vivo (23) . Prior studies also ruled out a contribution for the β subunit, as substitution or elimination of potential PKA phosphorylation sites did not perturb β-adrenergic regulation (24) (25) (26) (27) , although other consensus PKA sites are present in the N-terminal regions of the protein. We found that β subunit binding to α 1C , but not PKA phosphorylation of β, is absolutely essential for the augmentation of Ca 2+ current and cardiac contractile response to β-adrenergic PKA stimulation. These findings identify the key regulatory mechanisms impacting β-adrenergic regulation of Ca 2+ influx and contractility in the heart. Ca 2+ channel β-subunit interactions with pore-forming α-subunits are long-thought to be obligatory for channel trafficking to the cell surface and for tuning of basal biophysical properties in many tissues. Unexpectedly, we demonstrate that transgenic expression of mutant α 1C subunits lacking capacity to bind Ca V β can traffic to the sarcolemma in adult cardiomyocytes in vivo and sustain normal excitation-contraction coupling. However, these β-less Ca 2+ channels cannot be stimulated by β-adrenergic pathway agonists, and thus adrenergic augmentation of contractility is markedly impaired in isolated cardiomyocytes and in hearts. Similarly, viral-mediated expression of a β-subunit-sequestering peptide sharply curtailed β-adrenergic stimulation of WT Ca 2+ channels, identifying an approach to specifically modulate β-adrenergic regulation of cardiac contractility. Our data demonstrate that β subunits are required for β-adrenergic regulation of Ca V 1.2 channels and positive inotropy in the heart, but are dispensable for Ca V 1.2 trafficking to the adult cardiomyocyte cell surface, and for basal function and excitation-contraction coupling.
Cardiac Ca V 1.2 channels require β subunits for β-adrenergic-mediated modulation but not trafficking Figure 1D ). Second, we exploited the T1066Y/ Q1070M mutations that impart relative DHP-resistance (32, 33) to block Ca 2+ currents from endogenous DHP-sensitive Ca V 1.2 with nisoldipine and isolate Ca 2+ current from transgenic pWT α 1C or AID-mutant α 1C channels. Compared with cardiomyoctes isolated from NTG control mice, cardiomyocytes isolated from both pWT and AID-mutant α 1C transgenic mice had increased peak Ca 2+ currents, and substantial peak Ca 2+ currents remaining after exposure to nisoldipine (Figure 1, E and F) . Third, field-stimulated contraction of cardiomyocytes isolated from transgenic AID-mutant α 1C mice persisted in the presence of 300 nM nisoldipine ( Figure 1, I and J), similar to the contraction of cardiomyocytes isolated from transgenic pWT α 1C mice in the presence of nisoldipine. Contraction of cardiomyoyctes isolated from NTG was markedly inhibited by nisoldipine ( Figure 1, G and H) . Overall, these results demonstrate that transgenic β-less AID-mutant α 1C channels traffic to the sarcolemma and trigger E-C coupling in cardiomyocytes. This is in stark contrast to the necessary role of β binding for surface trafficking and function of Ca V 1.2 channels reconstituted in heterologous cells (Supplemental Figure 1 , A and B), or expressed in hippocampal neurons (34) .
We also considered that endogenous WT α 1C channels could couple with AID-mutant α 1C channels to facilitate trafficking of β-less channels to the surface membranes in cardiomyocytes, which could be the basis for the observed differences between cardiomyocytes and heterologous expression systems. To determine whether coupling-induced trafficking could occur, we coexpressed either DHP-resistant pWT α 1C or DHP-resistant AID-mutant α 1C with both WT α 1C and β 2 subunits in tsA201. In the presence of nisoldipine, which inhibits the WT α 1C channels, tsA201 cells expressing the AID-mutant α 1C channels had no remaining Ca 2+ current (Supplemental Figure 1C , right), whereas cells expressing the DHP-resistant pWT α 1C had remaining current (Supplemental Figure 1C, left) , implying that at least in tsA201 cells, β-less channels were unable to "hitchhike" to the membrane with WT channels.
PKA modulation of Ca V 1.2 channels is dependent on α 1C -β interactions. In heterologous expression studies, β subunits not only enable α 1C surface trafficking, but also can differentially induce, depending on β subunit isoform, a hyperpolarizing shift in the voltage dependence of Ca V 1.2 activation and increase the channel open probability (P o ) (12, 27) . We assessed the biophysical properties of the transgenic β-less AID-mutant α 1C channels compared with transgenic pWT Ca 2+ channels. Surprisingly, normalized current-voltage (I-V) relationships of nisoldipine-resistant transgenic pWT and AID-mutant α 1C channels were remarkably similar ( Figure 2A) . The midpoint potentials, derived from a Boltzmann function, for steady-state activation demonstrated a small, nonsignificant 1-mV hyperpolarizing shift for the AID-mutant channels compared with control pWT channels ( Figure 2B ), whereas the slope factors for the 2 channel types were not different ( Figure  2C ). Furthermore, the inactivation kinetics of nisoldipine-resistant Ca 2+ currents were not significantly different at any test potential between cardiomyocytes isolated from pWT and AID-mutant α 1C , respectively ( Figure 2D ). Therefore, in adult cardiomyocytes, Ca V 1.2 channels comprised of transgenic β-less α 1C have similar voltage dependence of activation and inactivation kinetics as transgenic pWT Ca V 1.2 channels.
Results
β-less Ca V 1.2 channels traffic to membrane in adult cardiomyocytes. Alanine substitutions of 3 conserved residues-Y467, W470, and I471-in rabbit α 1C AID ( Figure 1A ) increases the K D of β subunit binding from 5 nM to greater than 6 M (28-31). β 2 subunits failed to coprecipitate with the AID-mutant α 1C when coexpressed with AID-mutant α 1C in tsA201 cells (Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/ JCI123878DS1) confirming the critical importance of this region for β binding. We then created transgenic mice with cardiac-specific and doxycycline-inducible expression of N-terminal 3X-FLAG-tagged dihydropyridine-resistant (DHP-resistant) (T1066Y/Q1070M) (32, 33) AID-mutant rabbit α 1C ( Figure 1B ). Controls were provided by transgenic FLAG-tagged DHP-resistant α 1C subunits with WT AIDs, termed pseudo-WT (pWT) α 1C . Coimmunoprecipitation experiments from transgenic mice hearts confirmed that pWT α 1C associates with endogenous β subunit, but AID-mutant α 1C does not ( Figure 1C ). The anti-β antibody recognizes all Ca V β subunits, thus ruling out compensation from other β subunits in heart and thus confirming that the AID motif is essential to mediate the high-affinity binding between α 1C and β 2 in cardiomyocytes.
We assessed the impact of loss of β binding on AID-mutant α 1C subcellular localization and functional expression in cardiomyocytes using 3 complementary approaches. First, immunofluorescence experiments using anti-FLAG antibody on fixed cardiomyocytes indicated that both transgenic pWT α 1C and AID-mutant α 1C channels displayed a similar striated pattern consistent with surface membrane distribution and localization in in isolated cardiomyocytes. We achieved this by using adenovirus to overexpress a YFP-tagged 18-residue AID peptide derived from α 1C I-II loop (or a mutant YWI/AAA peptide as a control) in cultured adult guinea pig ventricular cardiomyocytes. We reasoned that this intervention would serve as a sponge for endogenous β subunits, leaving a majority of endogenous Ca V 1.2 channels devoid of β. In control cells expressing either GFP or YFP-tagged mutant (YWI/AAA) AID peptide incapable of binding β, 1 μM forskolin resulted in a robust 4-to 5-fold increase in whole-cell current amplitude ( Figure 3 , A, C, D, and F-H). By contrast, this response was sharply curtailed in cardiomyocytes overexpressing YFP-AID peptide ( Figure 3 , B, E, G, and H). Hence, β-less WT α 1C channels also demonstrate a marked insensitivity to PKA modulation.
We also considered 2 trivial explanations that could potentially account for the insensitivity of AID-mutant α 1C to PKA stimulation: (a) these channels were already phosphorylated by PKA under basal conditions, or (b) the β-adrenergic signaling pathway was compromised in cardiomyocytes from AID-mutant α 1C transgenic mice. To address whether transgenic AID-mutant α 1C channels were basally PKA phosphorylated, we used a cell-permeable cAMP-PKA inhibitor (Rp-8-Br-cAMPS), which functions by occupying cAMP binding sites thereby preventing activation of PKA holoenzyme. Rp-8-Br-cAMPS reverses isoproterenol-mediated upregulation of endogenous Ca V 1.2 by approximately 96% (23) . In transgenic AID-mutant mice cardiomyocytes, Rp-8-Br-cAMPS did not inhibit nisoldipine-resistant basal current (Supplemental Figure  2A) , ruling out the idea that AID-mutant α 1C channels were basally PKA phosphorylated. The integrity of the β-adrenergic pathway in transgenic AID-mutant mice cardiomyocytes was assessed by probing whether isoproterenol application led to phosphorylation of phospholamban, a well-known PKA target in the heart (35) . Western blotting indicated that phospholamban was appropriately phosphorylated at Ser 16 in response to isoproterenol (Supplemental Figure 2B) , confirming that the β-adrenergic signaling pathway was intact in AID-mutant transgenic mice cardiomyocytes.
β-adrenergic regulation of Ca V 1.2 does not require PKA phosphorylation of β subunits. The simplest explanation for the necessary role of α 1C -β interaction in PKA modulation of Ca V 1.2 is that the β-subunit contains phosphorylation site(s) that are vital to this regulation. Indeed, 2 phosphorylation sites on β 2 C-terminus (Ser 512 and Ser 570 ) were previously identified and proposed to play a role in PKA modulation of Ca V 1.2 (36) . However, a knockin mouse expressing a β 2 subunit truncated after Pro 501 displayed normal PKA modulation of Ca V 1.2, thus ruling out involvement of any putative C-terminal phosphorylation sites (24) . Nevertheless, it remained possible that previously unappreciated phosphorylation sites N-terminal to Pro 501 could mediate the increased Ca V 1.2 channel activity in response to activated PKA. Using both manual sequence analyses and several web-based PKA phosphorylation prediction tools (37-41), we identified 18 conserved consensus PKA phosphorylation sites in the N-terminus, SH3, and GK domains of human β 2b (residues labeled red in Supplemental Figure 3 ). We mutated all 18 Ser/Thr residues to Ala in human β 2b , and generated transgenic mice with inducible cardiomyocyte-specific expression of either GFP-tagged WT or 18-mutant β 2b subunits using the same bitransgenic system as in We next determined the sensitivity of Ca V 1.2 channels containing either transgenic pWT α 1C or AID-mutant α 1C to PKA modulation. In cardiomyocytes isolated from mice expressing transgenic pWT α 1C , 200 nM isoproterenol increased the nisoldipine-insensitive current by a mean of 1.9-fold ± 0.1-fold (Figure 2 , E-J), and shifted the V mid in the hyperpolarizing direction by a mean of 4.4 mV ( Figure 2B ). Similarly, forskolin, which directly activates adenylyl cyclase, thereby bypassing β-adrenergic receptors, increased transgenic pWT α 1C Ca 2+ currents by 1.8-fold ± 0.1-fold ( Figure 2 , H-J). In sharp contrast, Ca 2+ currents through transgenic AID-mutant α 1C Ca V 1.2 channels were insensitive to either isoproterenol ( Figure 2 , B, F, G, I, and J) or forskolin ( Figure 2 , H-J). In cardiomyocytes, there is an inverse relationship between total peak current and isoproterenol-induced or forskolin-induced fold increase in Ca 2+ current (27) . In cardiomyocytes isolated from transgenic pWT α 1C mice, we observed an inverse relationship between basal current density and isoproterenol-or forskolin-induced increase in Ca 2+ current ( Figure 2J ). For the transgenic AID-mutant β-less channels, however, activation of PKA by either forskolin or isoproterenol had no effect on Ca 2+ current, regardless of basal Ca 2+ current density ( Figure 2J ). To address whether the YWI/AAA mutations themselves produced an intrinsic insensitivity of the channel to PKA modulation, we sought to engender conditions under which there would be a predominance of β-less endogenous Ca V 1.2 channels Figure 1B . The WT and mutant β 2b transgenic mice were fed doxycycline for 1 week, thus ensuring high levels of expression of the GFP-tagged β 2 subunits ( Figure 4A ). We exploited the larger size of GFP-tagged β 2 subunits compared with endogenous β to determine relative expression of transgenic and native β 2 subunits ( Figure 4B ). Western blot indicated that in cardiomyocytes from transgenic mice, both GFP β 2 and GFP-mutant β 2 were markedly overexpressed (~9:1) compared with endogenous β 2 ( Figure 4C ). Isoproterenol increased peak Ca V 1.2 current by a mean of 1.5-fold ± 0.1-fold in GFP-WT β 2 -expressing cells and 1.6-fold ± 0.1-fold in GFP-mutant β 2 -expressing cells, respectively, similar to nontransgenic mice (Figure 4 , D-G). For both GFP-WT and GFP-mutant β 2b Ca 2+ channels, isoproterenol shifted the V mid of steady-state activation by -7.0 mV and -7.5 mV, respectively. These data indicate that, although the α 1C -β 2 interaction is necessary for β-adrenergic regulation of Ca V 1.2, direct PKA phosphorylation of β 2 is not involved.
β-adrenergic regulation of cardiac contractility requires PKA regulation of Ca V 1.2. We next exploited the findings that transgenic β-less AID-mutant α 1C channels are insensitive to PKA modulation to probe the specific role of Ca V 1.2 modulation in the positive inotropic effect of β-adrenergic agonists in both isolated cardiomyocytes and in the whole heart. In transgenic pWT α 1C cardiomyocytes, with endogenous Ca V 1.2 channels silenced with nisoldipine, isoproterenol produced a robust 100% increase in fractional shortening ( Figure 5, A and C) . By contrast, this response was severely diminished in cardiomyocytes expressing transgenic β-less AID-mutant α 1C channels in which isoproterenol produced a relatively meager 25% increase in fractional shortening ( Figure 5 , B and C). Consistent with the effects of isoproterenol on phospholamban phosphorylation (Supplemental Figure  2B) , isoproterenol enhanced relaxation in cardiomyocytes isolated from both pWT and AID-mutant α 1C transgenic mice ( Figure 5D ).
We then assessed the role of Ca V 1.2 modulation in β-adrenergic agonist-induced positive inotropy at the whole-organ level by inserting a pressure-transduced balloon into the left ventricle of Langendorff-perfused transgenic mice hearts. This approach enabled measurement of cardiac contractility independent of vascular or systemic effects. Hearts were paced at 400 beats per minute to remove the potentially confounding effect of heart rate variability on contractility (42) . After baseline measurements, 300 nM nisoldipine was infused into the coronary arteries via the aorta to suppress endogenous Ca V 1.2 channel currents. In hearts from nontransgenic mice, nisoldipine markedly reduced basal cardiac contractility due to the block of endogenous Ca V 1.2 channels ( Figure 5E ). In pWT α 1C hearts, infusion of nisoldipine yielded a comparatively weaker effect on basal contractility owing to the expression of DHP-resistant Ca 2+ channels ( Figure 5F ); a further infusion of 200 nM isoproterenol strongly increased cardiac contractility by 3.3-fold ( Figure 5 , G and I). By contrast, using the same experimental paradigm in hearts from β-less AID-mutant transgenic mice, the response to isoproterenol was nearly abolished, yielding an average increase in cardiac contractility of only 1.2-fold ( Figure 5, H and I ).
Discussion
Much of our current understanding regarding mechanisms underlying Ca V 1.2 trafficking and modulation derives from studies on recombinant channels reconstituted in heterologous cells. These such that PKA phosphorylation of either subunit is sufficient to mediate adrenergic regulation of Ca 2+ channels in the heart, or that PKA phosphorylation of the core Ca V 1.2 subunits, α 1C and β, are not necessary for β-adrenergic regulation of the Ca 2+ influx in the heart. This can be addressed by cross-breeding the transgenic mice harboring Ala substitutions of all PKA consensus sites in α 1C and β 2b . Although PKA phosphorylation of β is not required, β subunits, via binding to the I-II loop, could regulate pore opening and voltage-sensor movement. The domain I S6-AID linker forms a continuous helix that may act as a rigid rod through which β subunits modulate channel gating (51) .
The loss of β-adrenergic activation of Ca V 1.2 correlated with a markedly attenuated β-adrenergic contractile response. Originally proposed by Fabiato, Ca V 1.2 current has 2 distinct roles in E-C coupling: triggering the release of Ca 2+ from the sarcoplasmic reticulum (SR) and loading the cell (and SR) with Ca 2+ (52) . The loss of adrenergic regulation of Ca V 1.2 could affect both triggering of RyR2 and the loading of SR with Ca
2+
, thereby attenuating the adrenergically driven inotropic response. We believe that our findings are the first to demonstrate experimentally the vital role of β-adrenergic stimulation of Ca V 1.2 in shaping the flight-or-fight response in the heart, and validate a recently proposed mathematical model predicting that the loss of β-adrenergic stimulation of Ca V 1.2 would markedly limit Ca 2+ transients and contraction (53) . PKA and Ca 2+ / calmodulin-dependent protein kinase II (CaMKII) phosphorylation of RyR2 also enhances the open probability of the RyR2 Ca 2+ release channels in the SR by enhancing their sensitivity to cytosolic (54) and synchronizing SR Ca 2+ release (55) (56) (57) . It remains controversial, however, as to whether increasing the open probability of RyR2 is critically important for inotropic responses in the heart (58-60). We demonstrate that without augmented Ca V 1.2 current to load the cell with additional Ca 2+ and/or enhance RyR opening via Ca 2+ -induced Ca 2+ release, β-adrenergic agonist-induced phosphorylation of RyR2 and phospholamban does not result in substantial β-adrenergic augmentation of cardiac contractility.
In summary, we have found that Ca 2+ channel β-subunit binding to the pore-forming α 1C subunit is not required for trafficking and function of the Ca 2+ channel in the heart. The loss of α 1C -β 2 binding causes marked attenuation of β-adrenergic-induced stimulation of Ca V 1.2 and inotropy. Thus, we identify a new function for β subunits in the heart: as an essential component of the PKA-mediated augmentation of Ca V 1.2 and increased cardiac contractility that occurs during the physiological fight-or-flight response.
Methods
Reagents. Nisoldipine and Rp-8-Br-cAMPS were purchased from Santa Cruz Biotechnology. All other chemicals were acquired from MilliporeSigma.
Animals. The α 1C transgenic constructs were generated by fusing rabbit Cacna1c cDNA (accession X15539) to the modified murine α-myosin heavy chain (MHC) tetracycline-inducible promoter ("responder" line) vector (gift of Jeffrey Robbins and Jeffrey Molkentin, University of Cincinnati, Cincinnati, OH) (61, 62) . The α 1C subunit was engineered to be both DHP insensitive with the substitutions T1066Y and Q1070M (32, 33) and tagged with a 3X-FLAG epitope. We made alanine substitutions of 3 conserved residues, Y467, W470, and I471, in the AID domain of rabbit α 1C ( Figure 1A) . Two distinct gic stimulation of Ca V 1.2 is reduced with increased basal current density (27, (45) (46) (47) (48) (49) . Stratifying the magnitude of β-adrenergicmediated upregulation of Ca V 1.2 current by total basal current density attenuates this confounding variable ( Figure 2J and Figure 4G) .
Overall, we show that in cardiomyocytes, the AID motif is required for the high-affinity interaction between α 1C and β subunits, and that β-less Ca V 1.2 channels traffic to the dyad and produce currents that mediate normal E-C coupling. The AID-mutant β-less Ca 2+ currents were completely refractory to PKA activation. These findings, combined with our recent studies (23), fundamentally recast our views on mechanisms underlying Ca V 1.2 trafficking and PKA modulation in cardiomyocytes as they show that (a) it is possible for β-less channels to traffic to the cell surface, (b) β 2 binding to α 1C is indispensable for PKA modulation of Ca V 1.2, and that β-adrenergic regulation of Ca V 1.2 can be specifically attenuated by sequestering β subunits, and (c) conserved consensus PKA phosphorylation sites in α 1C (23) and β 2b are not required for β-adrenergic regulation of Ca V 1.2 in the heart. Further, we directly show that β-adrenergic modulation of Ca V 1.2 is critical for sympathetic augmentation of cardiac inotropy, which is essential for the fight-or-flight response.
When coexpressed with α 1 subunits in heterologous expression systems such as Xenopus oocytes or human embryonic kidney (HEK) cells, β subunits markedly augment current density by increasing membrane targeting and altering electrophysiological properties (6) (7) (8) . In the adult heart, however, Ca 2+ channels can traffic to the surface membrane without binding to β. How β-less α 1C channels traffic to the dyad in cardiomyocytes but not in a less complex system such as HEK cells is not yet clear. Although low-affinity interactions between heterologously expressed β subunit GK and SH3 domains and the Ca V 2.1 α subunit in oocytes have been described (50) , these potential interactions do not appear to be sufficient to rescue the trafficking of AID-mutant Ca V 1.2 channels in tsA-201 cells. Moreover, conditional knockout of Cacnb2 in adult cardiomyocytes caused only a 29% reduction in current density (19) .
Regardless of the mechanisms enabling trafficking to the cell surface, β-less Ca V 1.2 channels are functionally normal under basal conditions in adult cardiomyocytes. However, the β-less channels cannot be regulated by adrenergic-PKA stimulation, although the β subunit does not appear to be the functional target of PKA. To differentiate between the lack of β binding as opposed to the mutations in the AID as causative of the defect in β-adrenergic regulation of Ca V 1.2, we used the complementary approach of expressing using adenovirus, YFP-AID-and YFP-mutant AID-containing peptides in cultured adult guinea pig ventricular myocytes. The response to forskolin was markedly reduced by preventing β subunits from interacting with endogenous WT α 1C , implying that lack of β binding to α 1C is sufficient to prevent β-adrenergic regulation of Ca V 1.2 in the heart. Our studies cannot address where and when β subunits first interact with α 1C subunits in the heart.
Identifying the functional PKA target is more complicated. It is likely not solely α 1C , based on our prior studies eliminating all conserved consensus PKA phosphorylation sites in the α 1C subunit (23) . Likewise, it is not solely β, based on eliminating all conserved PKA phosphorylation sites in β 2 (Figure 4) . Thus, our findings suggest that either there is redundancy between α 1C and β subunits, jci. currents, the same protocol was repeated with steps between -50 mV to +50 mV in 10-mV increments. All experiments were performed at room temperature, 22°C ± 1°C. The parameters of voltage-dependent activation were obtained using a modified Boltzmann distribution:
, where I(V) is peak current, G max is maximal conductance, E rev is reversal potential, V mid is the midpoint, and V c is the slope factor. Whole-cell recordings of virally infected cultured guinea pig ventricular myocytes were conducted at room temperature as previously described (27, 67) . Patch pipettes typically had 1-2 MΩ series resistance when filled with internal solution containing 150 mM cesium-methanesulfonate, 10 mM EGTA, 5 mM CsCl, 1 mM MgCl 2 , 10 mM HEPES, and 4 mM MgATP (pH 7.3). Cells were perfused with normal Tyrode external solution during formation of gigaohm seal. After successful break-in to the whole-cell configuration, the perfusing medium was switched to an external recording solution containing 155 mM N-methyl-D-glucamine-aspartate, 10 mM 4-aminopyridine, 1 mM MgCl 2 , 5 mM BaCl 2 , and 10 mM HEPES (pH 7.4). Currents were sampled at 50 KHz and filtered at 5 KHz, and leak and capacitive currents were subtracted using a P/8 protocol.
Fractional shortening of isolated cardiomyocytes. Freshly isolated myocytes were superfused with a Tyrode's solution containing 1.0 mM CaCl 2 and 300 nM nisoldipine. Myocytes were field stimulated at 1 Hz. Percent contraction of sarcomere length was measured using the SarcLen module (Ionoptix) and calculated as the difference of shortest sarcomere length during a contraction subtracted from the relaxed sarcomere length, divided by the relaxed sarcomere length, all averaged over at least 8 contractions.
Ex vivo cardiac contractility. The cannulated hearts were retrogradely perfused on a Langendorff system with a modified Krebs solution (118.5 mM NaCl, 25 mM NaHCO 3 , 4.7 mM KCl, 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 11 mM glucose, 1.8 mM Ca 2+ ). Left ventricular (LV) pressure was measured using a balloon catheter connected to an APT-300 pressure transducer, which was connected to a PowerLab digitizer (ADInstruments). Hearts were paced at 400 beats per minute using electrodes connected to a pacing stimulator system. After initial assessment of cardiac contractility, 300 nM nisoldipine was perfused to silence endogenous Ca 2+ currents. The effects of nisoldipine on contractility were assessed after at least 3 minutes and on stabilization of LV pressures. Thereafter, 200 nM isoproterenol was perfused with 300 nM nisoldipine for at least 3 minutes. Peak LV pressure during the 3-minute period was used for the assessment of β-adrenergic agonist stimulation.
AID-mutant α 1C were created and studied. The results obtained from each of these lines were equivalent and therefore the data were pooled. The β 2b transgenic constructs were generated by ligating a N-terminal GFP-tagged human CACNB2b cDNA (accession AAG01473) to the tetracycline-inducible vector. These mice were bred with cardiac-specific (αMHC), doxycycline-regulated, codon-optimized reverse transcriptional transactivator (rtTA) mice (obtained via the Mutant Mouse Resource and Research Center [MMRRC]) (63) to generate double-transgenic mice. The α 1C transgenic animals received 0.2 g/kg doxycycline-impregnated food (Bio Serv catalog S3888) for 1-2 days and the GFP-β 2b transgenic mice received the doxycycline-impregnated food for 1 week to maximize expression.
Generation of adenoviral vectors and infection of guinea pig ventricular cardiomyocytes.
Replication-deficient adenoviral vectors expressing AID-YFP and AID-mutant YFP were generated using the AdEasy Adenoviral Vector System (Agilent Technologies) according to the manufacturer's instructions. Briefly, sequences for AID-YFP and AID-mutant YFP were PCR-amplified and cloned into pShuttle-CMV vector. After linearization with PmeI, shuttle vectors were electroporated into BJ5183 cells containing pAdEasy-1 viral plasmid. Positive recombinants were amplified, linearized with Pac I, and transfected into AD-293 cells using the calcium phosphate precipitation method. Transfected cells were monitored for development of adenoviral plaques, after which the cells were freeze-thawed and the lysate used to infect a 10-cm dish of 90% confluent HEK293 cells. Viral expansion and purification were carried out as previously described (64) .
Adult guinea pig ventricular myocytes were isolated by enzymatic digestion using a Langendorff perfusion apparatus, and cultured as previously described (27) . Animal treatment and use were in accordance with a protocol approved by the Columbia University Institutional Animal Care and Use Committee. Heart cells were infected 2-3 hours after plating with 5-20 μl adenoviral vector stock (≈10 11 -10 12 viral particles/ml).
Immunoprecipitation, immunoblots, and immunofluorescence. Cardiac lysates from 6-to 12-week-old doxycycline-fed transgenic mice were prepared from either whole hearts or isolated ventricular cardiomyocytes (65) . Immunoprecipitations were performed in modified RIPA buffer consisting of 50 mM Tris HCl; pH 7.4, 150 mM NaCl, Triton X-100 (0.25%), 10 mM EDTA, 10 mM EGTA, 10 μM Calpain inhibitor I, 10 μM Calpain inhibitor II, and Complete Mini tablets (1 per 7 ml), using anti-FLAG antibody (MilliporeSigma) overnight. Immune complexes were collected using protein A (Amersham) for 2 hours, followed by extensive washing. Proteins were size-fractionated, transferred to nitrocellulose membranes, and probed with anti-FLAG antibody (MilliporeSigma), anti-tubulin antibody (Santa Cruz Biotechnology), and custom anti-α 1C and anti-β 2 antibodies (65) . Detection was performed with a charge-coupled device camera (Carestream Imaging), and ImageQuant software was used for quantification. Isolated cardiomyocytes were fixed for 15 minutes in 4% paraformaldehyde, and indirect immunofluorescence was performed using a 1:200 rabbit anti-FLAG antibody and 1:200 FITC-labeled goat-anti-rabbit antibody (MilliporeSigma). Images were acquired using a confocal microscope.
Cellular electrophysiology. Membrane currents from isolated mouse ventricular cardiomyocytes (66) were measured by the wholecell patch-clamp method using a MultiClamp 700B amplifier and pCLAMP 10 software (Molecular Devices) as described (65) . The
